NanoViricides Inc (NNVC)
AMEXHealth CareBiotechnologySnapshot 2026-11-04
$1.38-3.50%
Close 2026-11-04 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · NNVC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | — | — | — | 0.0 | — | — | — | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 4.7 | 4.7 | 5.5 | 5.4 | 6.4 | 5.8 | 6.1 | 4.7 | 5.9 | 5.9 | 6.6 | 5.0 | 3.7 | 5.1 | 4.3 | 4.3 |
| Operating Income | (8.3) | (8.3) | (9.6) | (8.5) | (8.9) | (8.1) | (8.7) | (8.0) | (8.7) | (9.3) | (9.6) | (8.9) | (7.1) | (8.7) | (6.6) | (6.1) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | — | — | 0.8 | 1.0 | 2.6 | 3.1 | 0.2 | — |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | 0.2 | 0.2 | 0.1 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | 2.5 | 2.9 | 0.1 | — |
| Other Non-Operating Income / Expenses | 0.1 | 0.1 | 0.1 | 0.2 | 0.4 | 0.0 | (0.1) | (5.5) | 0.2 | 0.8 | (0.7) | (1.9) | 4.9 | (4.9) | (2.3) | (0.1) |
| EBT, Incl. Unusual Items | — | (8.2) | — | — | — | (8.1) | (8.8) | (13.4) | (8.4) | (8.6) | (10.3) | (10.7) | (2.2) | (13.6) | (8.9) | (6.2) |
| Income Tax Expense | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | ||||||||||||||||
| Net Income | (8.2) | (8.2) | (9.5) | (8.3) | (8.6) | (8.1) | (8.8) | (13.4) | (8.4) | (8.6) | (10.3) | (10.7) | (2.2) | (13.6) | (8.9) | (6.2) |
| Per Share | ||||||||||||||||
| Basic EPS | — | (0.41) | (0.63) | (0.70) | (0.74) | (0.70) | (0.81) | — | — | (0.13) | (0.17) | (0.19) | (0.04) | — | — | — |
| Diluted EPS | — | (0.41) | (0.63) | (0.70) | (0.74) | (0.70) | (0.81) | — | — | (0.13) | (0.17) | (0.19) | (0.09) | — | — | — |
| Basic Weighted Avg Shares | — | 20.2 | 15.1 | 11.9 | 11.6 | 11.5 | 10.9 | — | — | 64.9 | 60.1 | 57.7 | 56.6 | — | — | — |
| Diluted Weighted Avg Shares | — | 20.2 | 15.1 | 11.9 | 11.6 | 11.5 | 10.9 | — | — | 64.9 | 60.1 | 57.7 | 59.2 | — | — | — |
| Supplemental | ||||||||||||||||
| EBIT | (8.3) | (8.3) | (9.6) | (8.5) | (8.9) | (8.1) | (8.7) | (8.0) | (8.7) | (9.3) | (9.6) | (8.9) | (7.1) | (8.7) | (6.6) | (6.1) |
| Effective Tax Rate | — | — | — | — | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.